Susan Logan

Title: Susan Logan: Innovator in Peptoid-Peptide Macrocycles

Introduction

Susan Logan is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on peptoid-peptide macrocycles. Her research focuses on developing compounds that may have therapeutic applications in treating various diseases, including cancer.

Latest Patents

Susan Logan holds a patent for "Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same." This patent describes the creation of peptoid-peptide macrocycles that exhibit inhibitory activity towards the Wnt signaling pathway. The Wnt signaling pathway is known to be associated with cancer and other serious conditions, such as pulmonary fibrosis. The patent also outlines methods for synthesizing these macrocycles, as well as their potential applications in pharmaceutical compositions.

Career Highlights

Susan Logan is affiliated with New York University, where she conducts her research and collaborates with other scientists. Her work has garnered attention for its potential impact on the treatment of diseases linked to the Wnt signaling pathway. With her innovative approach, she continues to contribute to advancements in pharmaceutical science.

Collaborations

Some of her notable coworkers include Kent Kirshenbaum and Timothy W. Craven. Their collaborative efforts enhance the research environment and foster innovation in the field.

Conclusion

Susan Logan's work on peptoid-peptide macrocycles represents a significant advancement in pharmaceutical research. Her contributions may lead to new therapeutic options for patients suffering from serious diseases.